Obesity Linked To Increased Risk For Dementia
Obesity may increase adults' risk for having dementia, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their analysis of published obesity and dementia prospective follow-up studies over the past two decades shows a consistent relationship between the two diseases.
Obesity Significantly Raises Dementia Risk - Underweight Also Raises Risk
Being obese can increase the risk of Alzheimer's Disease by as much as 80 percent, according to a study in the May issue of Obesity Reviews.But it's not just weight gain that poses a risk. People who are underweight also havean elevated risk of dementia, unlike people who are normal weight or overweight.
Patent Claims Allowed Covering Samaritan's Alzheimer's Memory Recovery Drug In Australia
Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office.
EPIX Pharmaceuticals Initiates Phase 2b Program In Alzheimer's Disease
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it has begun its Phase 2b program in Alzheimer's disease through the initiation of a clinical trial of PRX-03140, its novel 5-HT4 agonist, in combination with donepezil (Aricept ).
Targeting Cell Membrane RAFTS Offers Novel Approach To Treat Alzheimer's And Other Diseases
JADO Technologies GmbH, the leading developer of RAFT intervention therapeutics, has announced he publication of a paper in Science demonstrating a potential novel strategy for therapeutic intervention in Alzheimer's and other diseases by targeting discrete sub-compartments in the cell membrane (RAFTS).
Ibuprofen Linked To Reduced Alzheimer's Risk
Researchers in the US studying a large patient population have shown that use of the anti-inflammatory and painkiller ibuprofen is linked to lower risk of developing Alzheimer's disease. Patients who used the drug for more than 5 years were 40 per cent less likely to develop the disease compared with patients who did not use that type of drug at all.
Alzheimer Scotland Supports Appeal Judgment On NICE Cost-effectiveness Disclosure
The Court of Appeal ruled in favour of the drug companies Pfizer and Eisai, by finding that the National Institute for Health and Clinical Excellence (NICE) should have allowed public access to the health economics model used to determine the cost-effectiveness of key treatments in people with early stage Alzheimer's.
Two Dozen New Celebrities Join The Alzheimer's Association Champion Awareness Campaign
Terrell Owens, Penny Marshall, Garry Marshall, Molly Sims, Wayne Brady, Leeza Gibbons, Anthony Anderson, John Glover, Lainie Kazan, Kathy Mattea, Elisabeth Hasselbeck, Bryant Gumbel, Ahmad Rashad, and Emerson Drive have joined celebrities such as Dick Van Dyke, Vivica Fox, Olympia Dukakis, Natal.
Pin1 Is Beneficial In Alzheimer's Disease, Detrimental To Some Forms Of Dementia
The most common form of dementia, Alzheimer's disease, and a relatively rare hereditary form of dementia, frontotemporal dementia with parkinsonism-17, share a common pathology: Both are the result of an overaccumulation of tau proteins, which form tangled lesions in the brain's neurons and eventually lead to the collapse of the brain cells responsible for memory.
Ground Breaking New Insight Into The Development Of Alzheimer's Disease
According to estimates there are 85, 000 Alzheimer patients in our country and approximately 20, 000 new cases every year. This spectacular increase is due to the increasing ageing population. Unfortunately it is still unclear precisely which ageing process forms the basis of this spectacular rise in the occurrence of the disease.